• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Glaxo Spurns Pfizer, Drugs on Your Fingertips

By
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Down Arrow Button Icon
March 23, 2018, 1:33 PM ET

Good morning and happy Friday, readers! This is Sy.

I’m traveling today so we’ll have to leave you with a short one going into the weekend.

Read on for the day’s news, and we’ll be back on Monday!

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

Another day, another health care data breach. Health care is a prime target for hacks, ransomware, and other assorted digital delinquency. But the nature of such cyber attacks can take many forms, as demonstrated by the case of ATI Physicial Therapy. The Illinois-based firm notified more than 35,000 patients about a possible data breach which "could include a combination of Social Security numbers, driver’s license or state identification numbers, financial account numbers, Medicare or Medicaid identification numbers, and medical record numbers, along with a wide range of medical information," Healthcare IT News reports. (Healthcare IT News)

INDICATIONS

Glaxo surges after spurning Pfizer. Shares of British drug giant GlaxoSmithKline soared 5% on Friday after the company announced it was withdrawing its potential bid for Pfizer's consumer health care business (such a deal would have rung in as much as $20 billion for Pfizer). GSK has a tangible interest in the consumer health field (its CEO, Emma Walmsley, oversaw Glaxo's own unit in this space before her her promotion to the top perch). "While we will continue to review opportunities that may accelerate our strategy, they must meet our criteria for returns and not compromise our priorities for capital allocation," Walmsley said in a statement. (Reuters)

THE BIG PICTURE

The drug crisis at your fingertips. Just how bad is the U.S. drug addiction crisis? You may have (very small) traces of cocaine or heroin on your hands without even realizing it, according to a new study in the journal Clinical Chemistry. "Scientists have discovered that both drugs have become so widely used that 13% of people have traces of them on their fingers, without realizing it. That means that a little over one in ten people are unknowingly walking around with drugs on their hands," writes my colleague Emily Price. (Fortune)

REQUIRED READING

What Elon Musk's Compensation Deal Means for Tesla Motors, by Kirsten Korosec

Is Snapchat's Redesign Brilliant or Blunder? by Christina Austin and Andrew Nusca

The World's Biggest Floating Garbage Dump Is Now Bigger Than Alaska, by David Meyer

South Korea to Crack Down on Overworking By Literally Shutting Off Computers, by Natasha Bach

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortune newsletters.
About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Hims Hair loss treatment
HealthDietary Supplements
Hims Hair Loss Review 2025: Pros, Cons, and More From Hands-On Testing
By Christina SnyderDecember 22, 2025
12 hours ago
David Ko stands in front of a blue and purple "Fortune" background.
Healthchief executive officer (CEO)
The CEO behind the world’s top sleep and meditation app says most leaders are operating at ‘about 20%’ without a ‘fully recharged’ battery
By Sasha RogelbergDecember 19, 2025
4 days ago
Johnson
PoliticsCongress
Republican leaders powerless to stop a January vote on healthcare after moderates defect on ACA subsidies
By Joey Cappelletti and The Associated PressDecember 18, 2025
4 days ago
Simple App as best intermittent fasting app
HealthWeight Loss
The Best Intermittent Fasting Apps of 2025: From Nutrition Experts
By Christina SnyderDecember 18, 2025
4 days ago
Noom as best weight loss program
HealthWeight Loss
Best Weight Loss programs of 2025: Expert Tested
By Christina SnyderDecember 18, 2025
4 days ago
social epidemic
HealthLoneliness
25 years after a Harvard professor told America it was ‘bowling alone,’ the loneliness epidemic is starker than ever
By Peter Smith and The Associated PressDecember 18, 2025
4 days ago

Most Popular

placeholder alt text
Future of Work
Meet a 55-year-old automotive technician in Arkansas who didn’t care if his kids went to college: ‘There are options’
By Muskaan ArshadDecember 21, 2025
2 days ago
placeholder alt text
Success
Billionaire philanthropy's growing divide: Mark Zuckerberg stops funding immigration reform as MacKenzie Scott doubles down on DEI
By Ashley LutzDecember 22, 2025
8 hours ago
placeholder alt text
Success
Multimillionaire musician Will.i.am says work-life balance is for people 'working on someone else’s dream'—he grinds from 5-to-9 after his 9-to-5
By Orianna Rosa RoyleDecember 21, 2025
1 day ago
placeholder alt text
Success
Former U.S. Secret Service agent says bringing your authentic self to work stifles teamwork: 'You don’t get high performers, you get sloppiness'
By Sydney LakeDecember 22, 2025
11 hours ago
placeholder alt text
Travel & Leisure
After pouring $450 million into Florida real estate, Larry Ellison plans to lure the ultrarich to an exclusive town just minutes from Mar-a-Lago
By Marco Quiroz-GutierrezDecember 22, 2025
12 hours ago
placeholder alt text
Future of Work
A Walmart employee nearly doubled her pay after entering its pipeline for skilled tradespeople. 'I was able to move out of my parents' house'
By Anne D'Innocenzio and The Associated PressDecember 20, 2025
2 days ago